![]() |
市場調查報告書
商品編碼
2041728
心血管保健品市場預測至2034年-按類型、成分、劑型、通路和地區分類的全球分析Cardiovascular Health Supplements Market Forecasts to 2034 - Global Analysis By Type, Ingredient, Form, Distribution Channel and By Geography |
||||||
根據 Stratistics MRC 的數據,預計到 2026 年,全球心血管健康補充劑市場規模將達到 164 億美元,並在預測期內以 11.1% 的複合年成長率成長,到 2034 年將達到 381 億美元。
心血管保健品是一種旨在支持和改善心血管系統(包括心臟和血管)健康的營養補充。常見的心血管保健品成分包括Omega-3脂肪酸、Coenzyme Q10、鎂、鉀和多種B群維生素,這些成分均有助於改善心臟功能。這些補充劑旨在透過提供支持心臟功能的額外營養素,來解決高血壓、高膽固醇和氧化壓力等心血管疾病的風險因素。
根據美國疾病管制與預防中心(CDC)的數據,2021 年美國有超過 695,000 人死於心臟病,佔所有死亡人數的五分之一。
政府舉措
世界各國政府都在積極推行公共衛生宣傳活動和政策,強調心血管健康的重要性。各國政府與醫療機構合作,意識提升。此外,監管機構正在製定心血管保健品的品質、安全性和有效性標準,這增強了消費者對心血管疾病預防和管理的信心,並推動了市場成長。
高成本
研發和生產高品質的心血管保健品涉及大量的研究、測試和生產流程,這導致產品高成本。這種情況對低收入族群的影響尤其嚴重,造成他們在獲得有益心血管保健產品方面的不平等。此外,製藥公司承擔的行銷和分銷成本進一步推高了價格,阻礙了市場擴張。
健康意識日益增強
消費者越來越意識到生活方式選擇對自身健康的影響,包括有助於心血管健康的營養補充品。線上線下宣傳宣傳活動在傳播維護心臟健康重要性的訊息方面發揮著至關重要的作用。此外,人們正積極透過各種社群媒體和網路資源尋求飲食療法來改善高膽固醇和高血壓等心血管風險因素,這正在推動市場成長。
副作用
心血管保健品的品質和純度可能因產品而異。某些常用於心血管保健品的草藥,例如銀杏和大蒜,具有稀釋血液的作用,可能會增加服用抗凝血劑或接受手術患者的出血風險。同樣,過量攝取某些維生素和礦物質,例如維生素E和鎂,也會產生不良反應,這阻礙了市場成長。
新冠疫情的感染疾病
新冠疫情對全球心血管保健品市場造成了負面影響,北美和歐洲市場也是如此。封鎖措施、供應鏈中斷和經濟不確定性正在影響消費者的支出模式和購買行為。此外,供應鏈中斷也影響了心血管保健品的供應和分銷,導致產品供應和價格波動。這可能會阻礙市場成長。
在預測期內,合成補充劑領域預計將佔據最大佔有率。
合成膳食補充劑預計將佔據最大的市場佔有率,因為其旨在模擬天然化合物的功效,並且通常經過標準化處理,以確保劑量和效果的一致性。心血管補充劑中常用的合成成分包括合成Coenzyme Q10、葉酸和某些形式的維生素B。此外,製造商可能使用合成成分來確保配方精準、生產成本低廉,同時滿足特定的飲食限制和偏好,這推動了該細分市場的成長。
預計在預測期內,ω脂肪酸細分市場將呈現最高的複合年成長率。
由於富含必需脂肪酸,特別是促進心臟健康的Omega-3和ω-6脂肪酸,ω脂肪酸細分市場預計在預測期內將呈現最高的複合年成長率。這些脂肪酸在降低三酸甘油酯水平、降低血壓和減輕血管發炎方面發揮著至關重要的作用,所有這些都有助於維護心血管健康。此外,消費者傾向於選擇ω脂肪酸補充劑,因為它方便快捷,能夠確保攝取足夠的這些必需營養素,這也推動了該細分市場的成長。
亞太地區在預測期內佔據最大的市場佔有率,這主要得益於其龐大的人口規模、較高的健康意識以及對心血管保健品的巨大需求。 Pharmavite LLC、Nature's Bounty Co.、安麗公司和雅培公司等領導企業均位於該地區,有助於提升消費者對心血管保健品安全性和有效性的信心。此外,潔淨標示、天然成分和永續採購等趨勢也推動了該地區的市場擴張。
由於人口老化和積極推行預防性醫療保健措施,預計歐洲在預測期內將實現最高的複合年成長率。歐洲各國政府和醫療機構正積極推廣公共衛生措施,有助於心血管疾病預防措施的廣泛普及。此外,嚴格的品質標準和標籤要求確保了產品的安全性和透明度,從而推動了該地區的成長。
According to Stratistics MRC, the Global Cardiovascular Health Supplements Market is accounted for $16.4 billion in 2026 and is expected to reach $38.1 billion by 2034 growing at a CAGR of 11.1% during the forecast period. Cardiovascular health supplements are dietary products designed to support and enhance the well-being of the cardiovascular system, which includes the heart and blood vessels. Key ingredients commonly found in cardiovascular health supplements include omega-3 fatty acids, coenzyme Q10, magnesium, potassium, and various B vitamins, all of which contribute to improved heart function. These supplements aim to address risk factors for cardiovascular diseases, such as high blood pressure, high cholesterol levels, and oxidative stress, by providing additional nutrients that support heart function.
According to the centers for disease control and prevention (CDC), in 2021, over 695,000 people in the U.S. died from heart disease, recorded as 1 out of every 5 deaths.
Government initiatives
Governments worldwide are promoting public health campaigns and policies that emphasize the importance of cardiovascular well-being. They collaborate with healthcare organizations to raise awareness about the risks of cardiovascular diseases and the role of a healthy lifestyle, including proper nutrition. Moreover, regulatory bodies establish standards for the quality, safety, and efficacy of cardiovascular health supplements, instilling consumer confidence in preventing or managing cardiovascular conditions, which boosts this market growth.
High costs
The development and production of high-quality cardiovascular health supplements involve extensive research, testing, and manufacturing processes, which contribute to the elevated costs associated with these products. This situation disproportionately affects individuals with lower incomes, creating an inequity in access to potentially beneficial cardiovascular health support. Additionally, the marketing and distribution expenses incurred by pharmaceutical companies further drive up prices, which are impeding this market expansion.
Growing health awareness
Consumers become increasingly conscious of the impact of lifestyle choices on their well-being, including nutritional supplements that support cardiovascular health. Educational campaigns, both online and offline, play a crucial role in disseminating information about the importance of maintaining a healthy heart. However, individuals are proactively seeking ways to address cardiovascular risk factors, such as high cholesterol and blood pressure, through dietary interventions through various social media and online resources, which are driving this market.
Side effects
The quality and purity of cardiovascular health supplements can vary significantly. Certain herbs commonly used in cardiovascular health supplements, such as ginkgo biloba or garlic, can have blood-thinning effects, which may increase the risk of bleeding in individuals taking blood thinners or undergoing surgery. Similarly, high doses of certain vitamins and minerals, such as vitamin E or magnesium, can have adverse effects when taken in excess, which is hampering this market size.
Covid-19 Impact
The COVID-19 pandemic has had negative impacts on the cardiovascular health supplement market globally, including in North America and Europe. Lockdowns, disruptions in the supply chain, and economic uncertainties have affected consumer spending patterns and purchasing behaviors. Additionally, supply chain disruptions have also affected the availability and distribution of cardiovascular health supplements, leading to fluctuations in product availability and pricing, which could potentially hinder market growth.
The synthetic supplements segment is expected to be the largest during the forecast period
The synthetic supplements segment is estimated to hold the largest share due to the fact that these are designed to mimic the benefits of naturally occurring compounds and are often standardized for consistency in dosage and effectiveness. Common synthetic ingredients in cardiovascular supplements include synthetic coenzyme Q10, folic acid, and certain forms of vitamin B. Moreover, manufacturers may use synthetic ingredients to ensure precise formulations and cost-effective production with specific dietary restrictions or preferences, which are driving this segment's growth.
The omega fatty acids segment is expected to have the highest CAGR during the forecast period
The omega fatty acids segment is anticipated to have highest CAGR during the forecast period due to the incorporation of essential fatty acids, particularly omega-3 and omega-6, to promote heart health. These fatty acids play a crucial role in reducing triglyceride levels, lowering blood pressure, and mitigating inflammation within blood vessels, all of which contribute to a healthier cardiovascular system. Additionally, consumers often turn to omega fatty acid supplements as a convenient way to ensure an adequate intake of these essential nutrients, which are boosting this segment's expansion.
Asia Pacific commanded the largest market share during the extrapolated period owing to the large and health-conscious population of the region, which exhibits a significant demand for cardiovascular supplements. This region is home to some of the major key players, such as Pharmavite LLC, Nature's Bounty Co., Amway Corporation, and Abbott Laboratories, that contribute to consumer confidence in the safety and efficacy of cardiovascular health supplements. In addition, the market reflects a trend toward clean labels, natural ingredients, and sustainable sourcing, thereby driving this region's expansion.
Europe is expected to witness highest CAGR over the projection period, owing to a growing aging population and a proactive approach to preventive healthcare. Governments and healthcare organizations in Europe actively promote public health initiatives, contributing to the rising adoption of preventive measures against cardiovascular diseases. Further, the regulatory landscape, characterized by stringent quality standards and labeling requirements, ensures product safety and transparency for consumers, which are propelling this region's growth.
Key players in the market
Some of the key players in the Cardiovascular Health Supplements Market include Natural Organics, Inc., NOW Health Group, Inc., Nordic Naturals, Bright Lifecare Pvt Ltd, DaVinci Laboratories of Vermont, Thorne HealthTech, Inc., Nestle, Amway, GNC Holdings, LLC, InVite Health, Sanofi S.A., USANA Health Sciences and Herbalife International of America, Inc.
In October 2023, announced a collaboration to co-develop and co-commercialize asset TEV'574, currently in Phase 2b clinical trials for the treatment of Ulcerative Colitis and Crohn's Disease, two types of inflammatory bowel disease.
In September 2023, Nestle has announced an agreement with Advent International to acquire a majority stake in Grupo CRM, a premium chocolate player in Brazil.
In March 2023, Nestle and UNESCO have announced a new partnership to provide young people with the resources and the skills they need to develop and carry forward innovative solutions to achieve positive social impact in their communities.